Results 11 to 20 of about 1,880,763 (299)

Tumor-infiltrating γδ T lymphocytes: pathogenic role, clinical significance and differential programming in the tumor microenvironment. [PDF]

open access: yesFrontiers in Immunology, 2014
There is increasing clinical evidence indicating that the immune system may either promote or inhibit tumor progression. Several studies have demonstrated that tumors undergoing remission are largely infiltrated by T lymphocytes (tumor-infiltrating ...
Elena eLo Presti   +2 more
doaj   +2 more sources

Advances in tumor-infiltrating B lymphocytes

open access: yesCentral European Journal of Immunology
In the landscape of tumor immunotherapy, T cell-mediated immune responses have consistently captured the attention, while the contributions of B cells have been neglected.
Jinxiu Chen   +4 more
core   +4 more sources

Supplementary Table from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

open access: yes, 2022
Supplementary Table from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic ...
Tara G. Hughes (15122800)   +19 more
core   +4 more sources

Tumor Infiltrating Lymphocytes in Ovarian Cancer [PDF]

open access: yesAsian Pacific Journal of Cancer Prevention, 2015
Several improvements in ovarian cancer treatment have been achieved in recent years, both in surgery and in combination chemotherapy with targeting. However, ovarian tumors remain the women's cancers with highest mortality rates. In this scenario, a pivotal role has been endorsed to the immunological environment and to the immunological mechanisms ...
GASPARRI, MARIALUISA   +8 more
openaire   +7 more sources

Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

open access: yes, 2022
Supplementary Figure from Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic ...
Tara G. Hughes (15122800)   +19 more
core   +2 more sources

Tumor-Infiltrating Lymphocytes in Melanoma [PDF]

open access: yesCurrent Oncology Reports, 2012
Adoptive cell therapy using tumor-infiltrating lymphocytes (TIL) is arguably the most effective treatment for patients with metastatic melanoma. With higher response rates than ipilimumab or IL-2, and longer durations of response than vemurafenib, TIL therapy carries the potential to transform current outcomes in melanoma, while also defining the way ...
Sylvia, Lee, Kim, Margolin
openaire   +2 more sources

Tumor-Infiltrating Lymphocytes in Wilms Tumor [PDF]

open access: yesIndian Journal of Medical and Paediatric Oncology, 2020
Abstract Purpose: T-lymphocytes-infiltrating tumors (TILs) are white blood cells (CD3+) found within the tumor and are thought to indicate a T-cell-mediated specific immune response. The purpose was to evaluate the presence and the subtypes of TILs in Wilms tumor (WT) specimens.
Devendra Kumar Yadav   +3 more
openaire   +2 more sources

Tumor-infiltrating lymphocytes in the immunotherapy era [PDF]

open access: yesCellular & Molecular Immunology, 2020
The clinical success of cancer immune checkpoint blockade (ICB) has refocused attention on tumor-infiltrating lymphocytes (TILs) across cancer types. The outcome of immune checkpoint inhibitor therapy in cancer patients has been linked to the quality and magnitude of T cell, NK cell, and more recently, B cell responses within the tumor microenvironment.
Sterre T, Paijens   +3 more
openaire   +2 more sources

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung cancer

open access: yes, 2021
Raw data for "Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small cell lung ...
McGrail, D (via Mendeley Data)   +1 more
core   +1 more source

The role of tumor-infiltrating lymphocytes in cholangiocarcinoma

open access: yesJournal of Experimental & Clinical Cancer Research, 2022
Abstract Cholangiocarcinoma (CCA) is the second most common primary liver cancer and associated with a dismal prognosis due to the lack of an efficient systemic therapy. In contrast to other cancers, new immunotherapies have demonstrated unsatisfactory results in clinical trials, underlining the importance of a deeper understanding of
Dong Liu   +8 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy